Get started
Author

Sanaz Attaripour Isfahani

KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.
2025 · Laura Cif, Diane Demailly, et al. · PubMed · 9
PDF
Towards a Generalizable Speech Marker for Parkinson's Disease Diagnosis
2025 · Siniukov, Maksim, Xing, Ellie, et al. · arXiv (Cornell University) · 2
PDF
The Impact of Botulinum Neurotoxin Therapy on Cognition and Neuropsychological Testing: A Case Report
2024 · Eshita Shah, Hayley Kristinsson, et al. · Toxicon · 2
Hormone Therapy and Parkinson’s Disease: A Case-Control Study
2025 · K. Tsutsumi, C. Xiao, et al. · Parkinsonism & Related Disorders · 1
In Memorium Mark Hallett, MD
2026 · Katharine E. Alter, Karp I. Barbara, et al. · Muscle & Nerve
Promising Outcomes Using Reduced-Intensity Conditioning Autologous Stem Cell Transplantation for Autoimmune Diseases
2026 · Piyanuch Kongtim, Piyatida Chumnumsiriwath, et al. · Transplantation and Cellular Therapy
Detection of Novel Acoustic Biomarkers for Parkinson’s Disease through a Machine Learning-Based Composite Spectrogram Analysis
2026 · Kotaro Tsutsumi, Peter D. Chang, et al. · medRxiv
PDF
Cost-effectiveness of Erenumab versus Surgical Trigger Site Deactivation for the Treatment of Migraine Headaches: A Systematic Review
2021 · Nikhil Shah, Ruben Castro, et al. · Plastic & Reconstructive Surgery Global Open
Botulinum Toxin for Pediatric Patients, Who? For What? When?
2020 · Sanaz Attaripour Isfahani, Katharine Alter · Springer eBooks
A young woman with dystonia of a foot
2019 · Sanaz Attaripour Isfahani, Mark Hallett · Swiss Archives of Neurology Psychiatry and Psychotherapy
PDF
Works count: 10
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type